{"active_ingredient":["Active ingredient Polyvinyl Alcohol 1.4%"],"dosage_and_administration":["Directions • instill 1 to 2 drops in the affected eye(s) as needed"],"effective_time":"20180725","id":"832490f0-0c9e-48b7-968f-f1f3287fb86d","inactive_ingredient":["Inactive ingredients dibasic sodium phosphate, edetate disodium, monobasic sodium phosphate, sodium chloride, purified water. Phosphoric acid and/or sodium hydroxide may be added to adjust pH. PRESERVATIVE ADDED: benzalkonium chloride 0.01%"],"indications_and_usage":["Uses • to prevent further irritation • to relieve dryness of the eye"],"keep_out_of_reach_of_children":["Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away"],"openfda":{},"package_label_principal_display_panel":["Package/Label Principal Display Panel MAJOR® NDC 0904-5017-35 LiquiTears Polyvinyl Alcohol 1.4% Lubricant Eye Drops (Sterile) Relieves Burning due to Dryness of the Eye Compare to Active Ingredient of Liquifilm Tears®* 1/2 FL. OZ. (15 mL) Carton"],"purpose":["Purpose Lubricant"],"questions":["Questions ? Serious side effects associated with use of this product may be reported to 1800-323-0000 *MAJOR LIQUITEARS IS NOT MANUFACTURED OR DISTRIBUTED BY ALLERGAN, INC. OWNER OF THE REGISTERED TRADEMARK, LIQUIFILM TEARS®."],"set_id":"d639b093-9907-4b20-a3a1-c19bfcedb5d7","spl_product_data_elements":["LiquiTears Polyvinyl Alcohol POLYVINYL ALCOHOL, UNSPECIFIED POLYVINYL ALCOHOL SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM EDETATE DISODIUM SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM SODIUM CHLORIDE WATER BENZALKONIUM CHLORIDE"],"spl_unclassified_section":["Other information • store at 15° - 30°C (59° - 86°F) • keep tightly closed"],"version":"2","warnings":["Warnings • Do not use if solution changes color or becomes cloudy When using this product • do not touch tip of container to any surface to avoid contamination • replace cap after use Stop use and ask a doctor if • you experience eye pain, changes in vision, continued redness or irritation of the eye • condition worsens or persists for more than 72 hours"]}